Back
Direxion Daily Gold Miners Index Bull 2X Shares Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Buy
80
NUGT
Direxion Daily Gold Miners Index Bull 2X Shares
Last Price:
$184.80
Seasonality Move:
10.25%
Sell
34
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.91
Seasonality Move:
-18.07%
Buy
80
Direxion Daily Gold Miners Index Bull 2X Shares (NUGT)
is a Buy
Is Direxion Daily Gold Miners Index Bull 2X Shares a Buy, Sell or Hold?
-
The current Direxion Daily Gold Miners Index Bull 2X Shares [NUGT] share price is $179.01. The Score for NUGT is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
NUGT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.96. The Score for INKT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NUGT Stock Price Chart
What is Direxion Daily Gold Miners Index Bull 2X Shares's stock price today?
-
The Direxion Daily Gold Miners Index Bull 2X Shares share price today is $179.01Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUGT is experiencing slight selling pressure.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.96Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight selling pressure.
NUGT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.12 | Buy |
| Relative Strength Index (14 RSI): | 61.4 | Buy |
| Chaikin Money Flow: | -112593 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (146.62 - 174.94) | Buy |
| Bollinger Bands (100): | (101.3 - 162.66) | Buy |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 47.65 | Sell |
| Chaikin Money Flow: | -11714 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.88 - 12.8) | Buy |
| Bollinger Bands (100): | (12.31 - 15.41) | Sell |
NUGT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 173.74 | Buy |
| 20-day SMA: | 163.52 | Buy |
| 50-day SMA: | 152.95 | Buy |
| 200-day SMA: | 99.78 | Buy |
| 8-day EMA: | 175.39 | Buy |
| 20-day EMA: | 166.1 | Buy |
| 50-day EMA: | 151.22 | Buy |
| 200-day EMA: | 87.4 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.29 | Sell |
| 20-day SMA: | 11.54 | Buy |
| 50-day SMA: | 12.98 | Sell |
| 200-day SMA: | 11.84 | Buy |
| 8-day EMA: | 12.15 | Sell |
| 20-day EMA: | 12.09 | Sell |
| 50-day EMA: | 12.72 | Sell |
| 200-day EMA: | 12.23 | Sell |
Direxion Daily Gold Miners Index Bull 2X Shares Earnings Growth & NUGT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Direxion Daily Gold Miners Index Bull 2X Shares Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||